Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Signal Transduction
Stem Cells
Product Type
All Products
New Products
Small Molecules
Peptides
Antibodies
Jena Bioscience
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular Disease
Endocrinology
Immunology
Metabolic Disease
Neurological Disease
Pain & Inflammation
Respiratory Disease
Home »
Pharmacology » Ion Channels » Sodium Channels » Voltage-gated Sodium (NaV) Channels » KC 12291 hydrochloride
KC 12291 hydrochlorideCat No. 3251 |
Price and Availability |
|
Chemical Name: 3,4-Dimethoxy-N-methyl-N-[3-[(5-phenyl-1,2,4-thiadiazol -3-yl)oxy]propyl]benzeneethanamine hydrochloride |
|
Biological Activity
Orally active atypical voltage-gated sodium channel blocker. Inhibits sustained sodium currents (INaL) and prevents diastolic contracture in isolated atria in vitro (IC50 values are 9.6 and 0.55 - 0.79 μM respectively). Displays anti-ischemic, bradycardic and cardioprotective activity in vivo.Technical Data
M.Wt:449.99
Formula:C22H27N3O3S.HCl
Solubility:Soluble to 25 mM in water and to 50 mM in DMSO
Purity: >97 %
Storage:Desiccate at +4°C
CAS No:[181936-98-1]
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis and MSDS.
Resources
Certificate of Analysis / MSDS
Certificate of Analysis: View current batch
Material Safety Data Sheet: View current batch
References
Decking et al (1998) Cardioprotective actions of KC 12291. Naunyn-Schmied.Arch.Pharmacol. 358 547. Tamareille et al (2002) Anti-ischemic compound KC 12291 prevents diastolic contracture in isolated atria by blockade of voltage-gated sodium channels. J.Cardiovasc.Pharmacol. 40 346. John et al (2004) KC 12291: an atypical sodium channel blocker with myocardial antiischemic properties. Cardiovasc.Drug Rev. 22 17. Letienne et al (2006) Pharmacological characterisation of sodium channels in sinoatrial node pacemaking in the rat heart. Eur.J.Pharmacol. 530 243.If you know of a useful citation for this product please let us know.
Keywords: KC 12291 hydrochloride, Orally, active, atypical, Na+, blockers, cardioprotective, Sodium, NaV, Channels, voltage-gated, voltage-dependent, KC12291, hydrochloride
Buy Now / Print Quote
Find multiple products by catalog number
New Products in this Area
Licarbazepine
Active metabolite of oxcarbazepine (Cat. No. 3864)
OxcarbazepineAnticonvulsant; inhibits Na+ channel activity
RufinamideProlongs inactivation of sodium channels; anticonvulsant
Sign-up for new product e-alerts
New Product Guide
Highlights over 250 new products added in 2009/10. Request a copy or view PDF today.




